BPC-157
Body protection compound 157 with tissue repair and gut protection narratives.
PreclinicalModerate uncertaintySyntheticRepair
Key facts
Common routesSubcutaneous, intramuscular, oral
Half-life4-6 hours
Typical range250-500 mcg/day
Summary
BPC-157 is a synthetic fragment of a gastric protein, popularly described as a repair-focused peptide. Most user narratives focus on tendon, ligament, and gut recovery. Evidence is largely preclinical and anecdotal, so dosing and outcomes vary widely.
This page is a research summary and not medical guidance. Always cross-check sources and risks.
Mechanism notes
Tissue repair signaling
Proposed modulation of angiogenesis and collagen organization in preclinical models. These effects are not fully mapped in humans.
Gastrointestinal protection
Often positioned as mucosal protective support. Human data is limited; most discussion is community-driven.
Dosing patterns
Repair focus
Typical community range: 250-500 mcg per day.
Protocols often run 2-6 weeks, then reassess based on response.
Localized injury support
Some users split doses or inject near the injury site. Evidence for site-specific effects is anecdotal only.
Evidence snapshot
Evidence is mostly animal models and mechanistic research. There are limited controlled human trials for musculoskeletal outcomes. Reported outcomes are variable and often confounded by concurrent therapies.
Preclinical
Tendon healing and gut protection findings in rodent models.
Human data
Sparse and not standardized; mostly case reports.
Safety considerations
Commonly reported issues include injection site irritation and headaches. Risk framing is conservative due to limited human trials.
Common cautions
- Unknown long-term exposure profile
- Quality control variance between suppliers
- Potential interactions with other peptides or therapies